Healthcare & Pharma

PIU’ MEDICAL COMUNICAZIONE INTERMEDIA DURANTE IL PERIODO DI STABILIZZAZIONE

33m

PIU’ MEDICAL INTERIM COMMUNICATION DURING THE STABILIZATION PERIOD

PIU’ MEDICAL PIÙ MEDICAL AMMESSA ALLE NEGOZIAZIONI SU EURONEXT GROWTH MILAN

33m

PIU’ MEDICAL SPA

38m

PLx Pharma Inc.

PMV Pharmaceuticals, Inc.

60m

PNV

712m

POD

35m

POINT Biopharma Global Inc.

POLARITYTE, INC.

POXEL

12m

PPD, Inc.

PPD, Inc.

PRA Health Sciences, Inc.

PREDILIFE

7.1m

PRIM S.A

PRIM, S.A.

PRIM, S.A.

224m

PRO DEX INC

199m

PRO MEDEX

301m

PROCEPT BioRobotics Corp

1.1bn

PROCYON CORP

1.6m

PROGENITY, INC.

PSYCHEMEDICS CORP

15m

PTC Therapeutics, INC.

7.4bn

PZ Cormay S.A.

41m

Pacific Biosciences of California, INC.

477m

Pacific Health Care Organization INC

14m

Pacira BioSciences, Inc.

995m

Palatin Technologies INC

25m

Palisade Bio, INC.

328m

Panacea Biotec Limited

33bn

Panacea Life Sciences Holdings, INC.

711k

Panbela Therapeutics, Inc.

54k

Paragon 28, Inc.

Paratek Pharmaceuticals, Inc.

Pardes Biosciences, INC.

Park Dental Partners, Inc.

82m

Pasithea Therapeutics Corp.

Passage BIO, Inc.

17m

Patterson Companies, INC.

Paxman AB (publ)

1.1bn

Paxman AB (publ)

1.1bn

Peak Processing Limited

23m

Pear Therapeutics, Inc.

Pediatrix Medical Group, Inc.

2.2bn

Peijia Medical Ltd. - B

2.8bn

Pelthos Therapeutics Inc.

94m

Pennant Group, Inc.

1.4bn

Pentixapharm Holding AG

54m